Cambridge-based Sinaptica Therapeutics, a company providing electromagnetic treatment for patients with neurodegenerative diseases, announced its receipt of FDA Breakthrough Device Designation for its non-invasive SinaptiStim - AD System, designed to treat cognitive and functional decline in Alzheimer's patients.
SinaptiStim uses neurostimulation and brain wave monitoring technologies with an AI...
A cross-sectional study found increased EHR use among primary care physicians was associated with improvement in some quality measures, like diabetes and hypertension control and adherence to breast cancer screening.
The study, published in JAMA Network Open and conducted through Brigham and Women's Hospital and Massachusetts General Hospital in 2021, examined 291 primary care physicians'...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Signify Health, which offers technology and analytics services to support value-based care arrangements, is expanding its in-home diagnostic and preventative services offering for Medicaid and Medicare Advantage plan members.
The program supports Signify's In-Home Health Evaluation service, assisting with the detection, diagnosis and management of some of the leading causes of morbidity and...
On Tuesday, Colorado-based remote patient monitoring company BioIntelliSense announced the acquisition of AlertWatch, a monitoring platform. AlertWatch aggregates data and provides clinicians with a composite view of patient vital sign trends.
The company received four FDA 510(k) clearances for its product offerings for operating rooms, labor and delivery units, and intensive care units....
Eyenuk received $25 million in Series A funding to expand access to its AI-powered eye-screening technology that enables autonomous detection of diabetic retinopathy (DR) during a patient's regular exam.
The recent raise was led by AXA IM Alts and joined by new and existing investors, including A&C Foelsgaard Alternativer ApS, T&W Medical A/S, KOFA Healthcare and Kendall Capital Partners...
During an earnings call Thursday, Walgreens Boots Alliance CEO Roz Brewer said the pharmacy retail giant plans to acquire a tech asset as it boosts its ambitions in healthcare.
"We're making important strides and consistent progress in building our next growth engine, the U.S. healthcare segment," Brewer said on the call.
Brewer said Walgreens' healthcare strategy is "coming to life" and is far...
California-based virtual healthcare provider HealthTap and multinational electronics company Samsung announced a strategic partnership to bring virtual healthcare to Samsung Smart TVs in the U.S.
HealthTap is a technology company and medical group providing virtual healthcare offerings through the web and health apps. The partnership extends HealthTap's services to Samsung TV owners, who will be...
NeuroFlow, a behavioral health company, secured a $25 million investment led by growth equity impact investor SEMCAP Health, bringing its total funding to $32 million.
The company raised $7.5 million in a Series A funding round in 2019 and $20 million in Series B financing in 2021.
WHAT THEY DO
NeuroFlow's cloud-based platform allows healthcare providers to track, assess and connect with patients...
Thirty-seven percent of adults used telemedicine within the past 12 months, according to a report by the CDC.
The analysis outlined the percentage of adults who used telemedicine in the past 12 months by geographic and sociodemographic characteristics based on the 2021 National Health Interview Survey (NHIS).
Women were more likely to report telehealth use, with 42% reporting using telemedicine...
